As filed with the Securities and Exchange Commission on March 27, 2006


SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_______________

SCHEDULE TO

(Rule 14d-100)

Tender Offer Statement under Section 14(d)(1) of the Securities

Exchange Act of 1934


Schering AG

(Name of Subject Company (issuer))

 

Dritte BV GmbH

Bayer Aktiengesellschaft
 (Name of Filing Persons (offerors))


Ordinary Shares,

no par value

(Title of Class of Securities)

DE0007172009

(CUSIP Number of Class of Securities)


American Depositary Shares

(each representing one Ordinary Share)

(Title of Class of Securities)

806585204

(CUSIP Number of Class of Securities)


Dr. Roland Hartwig

Bayerwerk, Gebaeude W11
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
+49 (214) 3081195

 

(Name, Address and Telephone Number of Person Authorized to Receive

Notices and Communications on Behalf of the Person(s) Filing Statement)

With copies to:

 

Charles Nathan, Esq.
John E. Sorkin, Esq.

Latham & Watkins LLP
885 Third Avenue
New York, New York 10022
(212) 906-1200

Dr. Joachim von Falkenhausen
Stefan Widder
Latham & Watkins LLP
Warburgstrasse 50
20354 Hamburg, Germany
+49 (40) 414030

________________

 

CALCULATION OF FILING FEE

 

Transaction Valuation*

Amount of Filing Fee

N/A

N/A


 

*

 

This filing relates solely to preliminary communications made before the commencement of a tender offer, so no fee is payable.

o

 

Check the box if any part of the filing fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

 

Amount Previously Paid:

Filing Party:

 

Form or Registration No.:

Date Filed:

 

ý

 

Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

 

 

 

 

Check the appropriate boxes below to designate any transaction to which the statement relates:

ý

 

third-party tender offer subject to Rule 14d-1.

o

 

issuer tender offer subject to Rule 13e-4.

o

 

going-private transaction subject to Rule 13e-3.

o

 

amendment to Schedule 13D under Rule 13d-2.

 

 

 

 

 

Check the following box if the filing is a final amendment reporting the results of the tender offer: o

 

 



 

 

Exhibit List

 

Description

99.1

 

Webpage regarding interviews with CEO in major newspapers and magazines

99.2

 

Bayer News Channel article "Bayer in media spotlight"

99.3

 

Bild am Sonntag article "More strength for new medicines," dated May 26, 2006

 

 



 

SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:  March 27, 2006

 

 

Bayer Aktiengesellschaft

 

 

 

 

By:

/s/  DR. ROLAND HARTWIG

 

 

Name:  Dr. Roland Hartwig

 

 

Title:   General Counsel

 

 

 

 

By:

/s/  DR. ALEXANDER ROSAR

 

 

Name:  Dr. Alexander Rosar

 

 

Title:   Head of Investor Relations

 

 

 

 

Dritte BV GmbH

 

 

 

 

By:

/s/  DR. ARMIN  BUCHMEIER

 

 

Name:  Dr. Armin  Buchmeier

 

 

Title:   Managing Director